Health Care · Pharmaceutical Preparations · Nasdaq · CIK 812796 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $0.36Day −0.08%Mkt cap $5M1Y −71.8%Off 52W high −94.2%Vol (1Y) 213.5%
Daily closing price, split-adjusted to the current basis; 3y shown of 3,614 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest3.3% of sh out |
| Days to cover1.1d |
| 13F net flow (QoQ)+0.01% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-07 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$494,623 |
| Earnings (TTM)-$11.0M |
| ROE−235.5% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−73.0% |
| 1Y−71.8% |
| 3Y−96.4% |
| 5Y−99.8% |
| 10Y−100.0% |
| Since incept. (ann.)−43.7% |
Total return through 2026-07-28 · series begins 2012-03-08. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)213.5% |
| Ann. volatility (3Y)226.5% |
| Sharpe (1Y)0.32 |
| Sharpe (3Y)0.20 |
| Max drawdown (1Y)−94.4% |
| Max drawdown (3Y)−98.2% |
| Beta (3Y vs SPY)1.72 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 120,267 | $141,915 | 0.81% | +49.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | 58,400 | $68,912 | 0.39% | new |
| VANGUARD FIDUCIARY TRUST CO | 53,914 | $63,619 | 0.36% | new |
| XTX Topco Ltd | 20,799 | $24,543 | 0.14% | −25.5% |
| MORGAN STANLEY | 3,592 | $4,239 | 0.02% | +0.0% |
| UBS Group AG | 2,346 | $2,768 | 0.02% | −93.1% |
| SBI Securities Co., Ltd. | 402 | $474 | 0.00% | +20000.0% |
| JPMORGAN CHASE & CO | 305 | $338 | 0.00% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-08 | −$0.28 | — | — | — |
| 2025-09-30 | 2025-11-07 | −$0.58 | — | — | — |
| 2025-06-30 | 2025-08-14 | −$0.82 | — | — | — |
| 2025-03-31 | 2025-05-09 | −$0.97 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-07 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
